EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Office
Amsterdam, Netherlands
Frank van de Manakker helps customers and organizations in the pharma, biotech, med-tech and health care industries identify and solve business challenges: from R&D output issues to product commercialization and patient perception. Has daily contact with customers and stakeholders within the Dutch life sciences & health ecosystem. Works with multidisciplinary EY teams and experts on customer-specific solutions. This leads to better operating results and process efficiency, as well as reduction of risks and costs. Is also involved in the development and growth of scale-ups and start-ups in the various innovation clusters.
He completed the master's program in pharmaceutical sciences (pharmaco-chemistry) at VU Amsterdam and earned his PhD at Utrecht University within the Department of Biopharmacy and Pharmaceutical Technology. Has worked at EY since 2015.
“EY has much more in-house than just finance and tax experts; it also invests in sector-specific expertise and experience. As such, EY obtains improved understanding of the specific business challenges our clients face, enabling us to serve them as appropriately as possible.”
How Frank is building a better working world
“From an early age I wanted to work in science within a multidisciplinary field in which different worlds come together. The life sciences and health industry is one such area in which digital technology, behavioral science, biology and chemistry conjoin. By assisting promising companies with the challenges they face, new treatments, drugs and medical devices are more likely to actually reach patients in the future. That's how I contribute to the future of human health.”